Loyal Animal Health Develops Drug to Extend Canine Lifespan

Pets like our beloved dogs offer more than constant companionship; they also provide emotional support. In fact, our pets are playing a more important part as Emotional Support Animals as we become more aware of different needs for mental health care. As such, more countries and airlines are now allowing pets to accompany us on flights. This also gives fur parents a chance to create more milestones with their furbabies. However, one can’t help but wish for a longer life for one’s pet. Dogs typically live around 10-13 years, depending on their breed, body size, genetics, and the quality of care they receive. Loyal Animal Health aims to help prolong that by developing medical pills to extend the lives of our canine friends.

Prolonging canine life

Together with scientists, veterinarians, engineers, operators, and creatives, Loyal Animal Health aims to help dogs live longer, healthier lives. The San Francisco–based biotechnology startup is developing medications that target age-related conditions in dogs. By addressing these issues early, they aim to delay their onset and reduce their impact over time. Currently, the company is developing three drugs: LOY-001, LOY-002, and LOY-003.

These three pills from Loyal Animal Health focus on specific needs for dogs. For large-breed dogs, LOY-001 and LOY-003 focus on reducing excess growth hormone in adulthood, which may help support better long-term health. Meanwhile, LOY-002 is designed for senior dogs aged 10 and above, targeting metabolic dysfunction. Although still in development, the success of these pills may help extend lifespan while maintaining quality of life as dogs age.

STAYing for longer

Beyond the pills, Loyal Animal Health is also conducting the STAY study, which acts as the final major trial to evaluate how effective LOY-002 is before going for an FDA approval. Recently, the company shared that the FDA Center for Veterinary Medicine has accepted its safety data for LOY-002, checking off two of three key steps required before the drug can be approved for market use. It’s also the first time the FDA has accepted safety data for a drug meant to extend lifespan. Although still being tested, this milestone is a step toward improving both the lifespan and well-being of our canine companions. Once it becomes available in the market, the LOY‑002 pill could change how we care for aging dogs while extending their quality time with us.

YouTube: This Next Billion-Dollar Startup Makes Longevity Drugs For Dogs (And What It Could Mean For Humans)

Photo credit: The images used are owned by Loyal Animal Health, Inc. and have been provided for press usage.
Sources: Kendra Cherry (VeryWellMind) / Benise Balaoing (ABS-CBN) / Jamie Lovejoy, DVM. (Pet MD)